Flutemetamol (18F)

氟[18F]美他酚

Report date: 2025/11/25 15:53:02
NME

Base Information

Drug NameFlutemetamol (18F)
Drug Alias NameFlutemetamolum (18F)氟[18F]特美醇flutemetamol F-18VizamylAH-110690 +[7] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsContrast agentsDiagnostic agentsCognitive Dysfunction +[9] 
Global Approved IndicationsContrast agentsCognition DisordersAlzheimer Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/10/25
Country/TerritoryUnited StatesNetherlandsNorway +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesNihon Medi-Physics Co LtdTianjin Hengrui Pharmaceutical Co LtdGe Healthcare +[8] 
Inactive CompaniesUtah State UniversityMaastricht University Medical CenterUniversity of Zurich
Active IndicationsContrast agentsDiagnostic agentsCognition Disorders +[4] 
Inactive IndicationsCognitive DysfunctionAtherosclerosisHydrocephalus, Normal Pressure +[5] 

Other Information

ATC CodeV09AX04
Related LinksWikipediaDrugBankKEGG